BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Repici M, Giorgini F. DJ-1 in Parkinson's Disease: Clinical Insights and Therapeutic Perspectives. J Clin Med 2019;8:E1377. [PMID: 31484320 DOI: 10.3390/jcm8091377] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Naren P, Cholkar A, Kamble S, Samim KS, Srivastava S, Madan J, Mehra N, Tiwari V, Singh SB, Khatri DK. Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay. JAD 2022. [DOI: 10.3233/jad-220682] [Reference Citation Analysis]
2 De Lazzari F, Agostini F, Doni D, Malacrida S, Zordan MA, Costantini P, Bubacco L, Sandrelli F, Bisaglia M. DJ-1 and SOD1 Act Independently in the Protection against Anoxia in Drosophila melanogaster. Antioxidants (Basel) 2022;11:1527. [PMID: 36009245 DOI: 10.3390/antiox11081527] [Reference Citation Analysis]
3 Min HK, Kim SH, Lee JY, Lee SH, Kim HR. DJ-1 controls T cell differentiation and osteoclastogenesis in rheumatoid arthritis. Sci Rep 2022;12:12767. [PMID: 35896699 DOI: 10.1038/s41598-022-16285-1] [Reference Citation Analysis]
4 Priyanka, Seth P. Insights Into the Role of Mortalin in Alzheimer’s Disease, Parkinson’s Disease, and HIV-1-Associated Neurocognitive Disorders. Front Cell Dev Biol 2022;10:903031. [DOI: 10.3389/fcell.2022.903031] [Reference Citation Analysis]
5 Bashirzade AA, Zabegalov KN, Volgin AD, Belova AS, Demin KA, de Abreu MS, Babchenko VY, Bashirzade KA, Yenkoyan KB, Tikhonova MA, Amstislavskaya TG, Kalueff AV. Modeling neurodegenerative disorders in zebrafish. Neurosci Biobehav Rev 2022;138:104679. [PMID: 35490912 DOI: 10.1016/j.neubiorev.2022.104679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Vrijsen S, Vrancx C, Del Vecchio M, Swinnen JV, Agostinis P, Winderickx J, Vangheluwe P, Annaert W. Inter-organellar Communication in Parkinson's and Alzheimer's Disease: Looking Beyond Endoplasmic Reticulum-Mitochondria Contact Sites. Front Neurosci 2022;16:900338. [DOI: 10.3389/fnins.2022.900338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Angelopoulou E, Bougea A, Papageorgiou SG, Villa C. Psychosis in Parkinson's Disease: A Lesson from Genetics. Genes (Basel) 2022;13:1099. [PMID: 35741861 DOI: 10.3390/genes13061099] [Reference Citation Analysis]
8 Behl T, Madaan P, Sehgal A, Singh S, Makeen HA, Albratty M, Alhazmi HA, Meraya AM, Bungau S. Demystifying the Neuroprotective Role of Neuropeptides in Parkinson's Disease: A Newfangled and Eloquent Therapeutic Perspective. Int J Mol Sci 2022;23:4565. [PMID: 35562956 DOI: 10.3390/ijms23094565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Walczak-nowicka ŁJ, Herbet M. Sodium Benzoate—Harmfulness and Potential Use in Therapies for Disorders Related to the Nervous System: A Review. Nutrients 2022;14:1497. [DOI: 10.3390/nu14071497] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Schmidt S, Vogt Weisenhorn DM, Wurst W. Chapter 5 – “Parkinson's disease – A role of non-enzymatic posttranslational modifications in disease onset and progression?”. Molecular Aspects of Medicine 2022. [DOI: 10.1016/j.mam.2022.101096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Jia F, Fellner A, Kumar KR. Monogenic Parkinson’s Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing. Genes 2022;13:471. [DOI: 10.3390/genes13030471] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 López-Grueso MJ, Padilla CA, Bárcena JA, Requejo-Aguilar R. Deficiency of Parkinson's Related Protein DJ-1 Alters Cdk5 Signalling and Induces Neuronal Death by Aberrant Cell Cycle Re-entry. Cell Mol Neurobiol 2022. [PMID: 35182267 DOI: 10.1007/s10571-022-01206-7] [Reference Citation Analysis]
13 Markovinovic A, Greig J, Martín-Guerrero SM, Salam S, Paillusson S. Endoplasmic reticulum-mitochondria signaling in neurons and neurodegenerative diseases. J Cell Sci 2022;135:jcs248534. [PMID: 35129196 DOI: 10.1242/jcs.248534] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
14 Storey CL, Williams RSB, Fisher PR, Annesley SJ. Dictyostelium discoideum: A Model System for Neurological Disorders. Cells 2022;11:463. [DOI: 10.3390/cells11030463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Solana-Manrique C, Sanz FJ, Torregrosa I, Palomino-Schätzlein M, Hernández-Oliver C, Pineda-Lucena A, Paricio N. Metabolic Alterations in a Drosophila Model of Parkinson's Disease Based on DJ-1 Deficiency. Cells 2022;11:331. [PMID: 35159141 DOI: 10.3390/cells11030331] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Behl T, Madaan P, Sehgal A, Singh S, Anwer MK, Makeen HA, Albratty M, Mohan S, Bungau S. Mechanistic Insights Expatiating the Redox-Active-Metal-Mediated Neuronal Degeneration in Parkinson's Disease. Int J Mol Sci 2022;23:678. [PMID: 35054862 DOI: 10.3390/ijms23020678] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Ujcikova H, Eckhardt A, Hejnova L, Novotny J, Svoboda P. Alterations in the Proteome and Phosphoproteome Profiles of Rat Hippocampus after Six Months of Morphine Withdrawal: Comparison with the Forebrain Cortex. Biomedicines 2022;10:80. [DOI: 10.3390/biomedicines10010080] [Reference Citation Analysis]
18 Tsoporis JN, Ektesabi AM, Gupta S, Izhar S, Salpeas V, Rizos IK, Kympouropoulos SP, Dos Santos CC, Parker TG, Rizos E. A longitudinal study of alterations of circulating DJ-1 and miR203a-3p in association to olanzapine medication in a sample of first episode patients with schizophrenia. J Psychiatr Res 2021;146:109-17. [PMID: 34971908 DOI: 10.1016/j.jpsychires.2021.12.049] [Reference Citation Analysis]
19 Prasuhn J, Brüggemann N. Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson's Disease. Genes (Basel) 2021;12:1840. [PMID: 34828446 DOI: 10.3390/genes12111840] [Reference Citation Analysis]
20 Haver HN, Scaglione KM. Dictyostelium discoideum as a Model for Investigating Neurodegenerative Diseases. Front Cell Neurosci 2021;15:759532. [PMID: 34776869 DOI: 10.3389/fncel.2021.759532] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Sanz FJ, Solana-Manrique C, Torres J, Masiá E, Vicent MJ, Paricio N. A High-Throughput Chemical Screen in DJ-1β Mutant Flies Identifies Zaprinast as a Potential Parkinson's Disease Treatment. Neurotherapeutics 2021. [PMID: 34697772 DOI: 10.1007/s13311-021-01134-2] [Reference Citation Analysis]
22 Song IK, Kim MS, Ferrell JE Jr, Shin DH, Lee KJ. Stepwise oxidations play key roles in the structural and functional regulations of DJ-1. Biochem J 2021;478:3505-25. [PMID: 34515295 DOI: 10.1042/BCJ20210245] [Reference Citation Analysis]
23 Behl T, Madaan P, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Chigurupati S, Alrashdi I, Bungau SG. Elucidating the Neuroprotective Role of PPARs in Parkinson's Disease: A Neoteric and Prospective Target. Int J Mol Sci 2021;22:10161. [PMID: 34576325 DOI: 10.3390/ijms221810161] [Reference Citation Analysis]
24 Gibson R, Dalvi SP, Dalvi PS. DJ-1 and Parkinson's disease. Brain Disorders 2021;3:100020. [DOI: 10.1016/j.dscb.2021.100020] [Reference Citation Analysis]
25 Jagaran K, Singh M. Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer's and Parkinson's Diseases. Int J Mol Sci 2021;22:9082. [PMID: 34445784 DOI: 10.3390/ijms22169082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Lim D, Dematteis G, Tapella L, Genazzani AA, Calì T, Brini M, Verkhratsky A. Ca2+ handling at the mitochondria-ER contact sites in neurodegeneration. Cell Calcium 2021;98:102453. [PMID: 34399235 DOI: 10.1016/j.ceca.2021.102453] [Reference Citation Analysis]
27 Lin Z, Chen C, Yang D, Ding J, Wang G, Ren H. DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65. Cell Death Dis 2021;12:715. [PMID: 34274951 DOI: 10.1038/s41419-021-04002-1] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
28 Vuletić V, Rački V, Papić E, Peterlin B. A Systematic Review of Parkinson's Disease Pharmacogenomics: Is There Time for Translation into the Clinics? Int J Mol Sci 2021;22:7213. [PMID: 34281267 DOI: 10.3390/ijms22137213] [Reference Citation Analysis]
29 Magnusen AF, Hatton SL, Rani R, Pandey MK. Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease. Front Neurol 2021;12:636139. [PMID: 34239490 DOI: 10.3389/fneur.2021.636139] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
30 Tsoporis JN, Drosatos IA, Gupta S, Amatullah H, Izhar S, Dos Santos CC, Salpeas V, Rigopoulos AG, Toumpoulis IK, Triantafyllis AS, Sakadakis E, Kavantzas N, Marshall JC, Rizos IK, Parker TG. Cytoprotective Mechanisms of DJ-1: Implications in Cardiac Pathophysiology. Molecules 2021;26:3795. [PMID: 34206441 DOI: 10.3390/molecules26133795] [Reference Citation Analysis]
31 Marques CR, Pereira-Sousa J, Teixeira FG, Sousa RA, Teixeira-Castro A, Salgado AJ. Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease. Cytotherapy 2021:S1465-3249(21)00228-0. [PMID: 34059421 DOI: 10.1016/j.jcyt.2021.04.002] [Reference Citation Analysis]
32 Chen R, Li W, Qiu Z, Zhou Q, Zhang Y, Li WY, Ding K, Meng QT, Xia ZY. Ischemic Postconditioning-Mediated DJ-1 Activation Mitigate Intestinal Mucosa Injury Induced by Myocardial Ischemia Reperfusion in Rats Through Keap1/Nrf2 Pathway. Front Mol Biosci 2021;8:655619. [PMID: 33996908 DOI: 10.3389/fmolb.2021.655619] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Bortolozzi A, Manashirov S, Chen A, Artigas F. Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson's disease. Pharmacol Ther 2021;227:107873. [PMID: 33915178 DOI: 10.1016/j.pharmthera.2021.107873] [Reference Citation Analysis]
34 Solana-Manrique C, Muñoz-Soriano V, Sanz FJ, Paricio N. Oxidative modification impairs SERCA activity in Drosophila and human cell models of Parkinson's disease. Biochim Biophys Acta Mol Basis Dis 2021;1867:166152. [PMID: 33892078 DOI: 10.1016/j.bbadis.2021.166152] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Razali K, Othman N, Mohd Nasir MH, Doolaanea AA, Kumar J, Ibrahim WN, Mohamed Ibrahim N, Mohamed WMY. The Promise of the Zebrafish Model for Parkinson's Disease: Today's Science and Tomorrow's Treatment. Front Genet 2021;12:655550. [PMID: 33936174 DOI: 10.3389/fgene.2021.655550] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
36 Petkovic M, O'Brien CE, Jan YN. Interorganelle communication, aging, and neurodegeneration. Genes Dev 2021;35:449-69. [PMID: 33861720 DOI: 10.1101/gad.346759.120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Erskine D, Koss D, Korolchuk VI, Outeiro TF, Attems J, McKeith I. Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders. Acta Neuropathol 2021;141:511-26. [PMID: 33515275 DOI: 10.1007/s00401-021-02266-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
38 Anastasi F, Masciandaro SM, Carratore RD, Dell'Anno MT, Signore G, Falleni A, McDonnell LA, Bongioanni P. Proteomics Profiling of Neuron-Derived Small Extracellular Vesicles from Human Plasma: Enabling Single-Subject Analysis. Int J Mol Sci 2021;22:2951. [PMID: 33799461 DOI: 10.3390/ijms22062951] [Reference Citation Analysis]
39 Tayarani-Najaran Z, Hadipour E, Seyed Mousavi SM, Emami SA, Mohtashami L, Javadi B. Protective effects of Lavandula stoechas L. methanol extract against 6-OHDA-induced apoptosis in PC12 cells. J Ethnopharmacol 2021;273:114023. [PMID: 33716081 DOI: 10.1016/j.jep.2021.114023] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Talebi M, Talebi M, Kakouri E, Farkhondeh T, Pourbagher-Shahri AM, Tarantilis PA, Samarghandian S. Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases. Int J Biol Macromol 2021;172:93-103. [PMID: 33440210 DOI: 10.1016/j.ijbiomac.2021.01.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
41 Bantle CM, Hirst WD, Weihofen A, Shlevkov E. Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson's Disease? Front Cell Dev Biol 2020;8:608026. [PMID: 33537300 DOI: 10.3389/fcell.2020.608026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
42 Wang T, Zhao N, Peng L, Li Y, Huang X, Zhu J, Chen Y, Yu S, Zhao Y. DJ-1 Regulates Microglial Polarization Through P62-Mediated TRAF6/IRF5 Signaling in Cerebral Ischemia-Reperfusion. Front Cell Dev Biol 2020;8:593890. [PMID: 33392187 DOI: 10.3389/fcell.2020.593890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
43 Overhoff M, De Bruyckere E, Kononenko NL. Mechanisms of neuronal survival safeguarded by endocytosis and autophagy. J Neurochem 2021;157:263-96. [PMID: 32964462 DOI: 10.1111/jnc.15194] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
44 Gentile F, Doneddu PE, Riva N, Nobile-Orazio E, Quattrini A. Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration. Int J Mol Sci 2020;21:E7471. [PMID: 33050475 DOI: 10.3390/ijms21207471] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
45 Solana-manrique C, Sanz FJ, Ripollés E, Bañó MC, Torres J, Muñoz-soriano V, Paricio N. Enhanced activity of glycolytic enzymes in Drosophila and human cell models of Parkinson's disease based on DJ-1 deficiency. Free Radical Biology and Medicine 2020;158:137-48. [DOI: 10.1016/j.freeradbiomed.2020.06.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
46 Miranda-Díaz AG, García-Sánchez A, Cardona-Muñoz EG. Foods with Potential Prooxidant and Antioxidant Effects Involved in Parkinson's Disease. Oxid Med Cell Longev 2020;2020:6281454. [PMID: 32832004 DOI: 10.1155/2020/6281454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
47 Bernaus A, Blanco S, Sevilla A. Glia Crosstalk in Neuroinflammatory Diseases. Front Cell Neurosci 2020;14:209. [PMID: 32848613 DOI: 10.3389/fncel.2020.00209] [Cited by in Crossref: 10] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
48 Farombi EO, Awogbindin IO, Owoeye O, Abah VO, Izomoh ER, Ezekiel IO. Kolaviron ameliorates behavioural deficit and injury to striatal dopaminergic terminals via modulation of oxidative burden, DJ-1 depletion and CD45R+ cells infiltration in MPTP-model of Parkinson's disease. Metab Brain Dis 2020;35:933-46. [PMID: 32430695 DOI: 10.1007/s11011-020-00578-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Wang J, Zhang H, Du A, Li Y. DJ-1 alleviates anoxia and hypoglycemia injury in cardiac microvascular via AKT and GSH. Mol Cell Probes 2020;53:101600. [PMID: 32445781 DOI: 10.1016/j.mcp.2020.101600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Jin W. Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression. J Clin Med 2020;9:E1256. [PMID: 32357493 DOI: 10.3390/jcm9051256] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Teixeira FG, Vilaça-Faria H, Domingues AV, Campos J, Salgado AJ. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease. Cells 2020;9:E315. [PMID: 32012897 DOI: 10.3390/cells9020315] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]